Global End Stage Renal Disease Treatment Competitive Landscape Professional Research Report 2024
Description
Global End Stage Renal Disease Treatment Competitive Landscape Professional Research Report 2024
Research Summary
End-stage renal disease (ESRD) treatment refers to the advanced medical interventions necessary for individuals whose kidneys have lost nearly all their function and can no longer adequately filter waste and excess fluids from the bloodstream. Hemodialysis and peritoneal dialysis are the most common treatments for ESRD, involving the removal of waste products and excess fluids from the body to maintain overall health and well-being. Additionally, kidney transplant surgery is often considered as a long-term solution, providing a functioning kidney from a living or deceased donor to replace the failed kidneys. The choice of treatment depends on individual health, lifestyle, and medical factors, and ESRD patients typically require ongoing medical management and dialysis or transplantation to sustain life when kidney function is severely impaired.
According to DIResearch's in-depth investigation and research, the global End Stage Renal Disease Treatment market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of End Stage Renal Disease Treatment include Fresenius, DaVita, Baxter, Nipro, B. Braun, Asahi Kasei, Nikkiso, WEGO, Newsol, Mayo Clinic, Guangdong Biolight, Sanxin Medtec, Medtronic, Jafron Biomedical, SWS Hemodialysis Care, Tianyi Medical etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of End Stage Renal Disease Treatment. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global End Stage Renal Disease Treatment market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the End Stage Renal Disease Treatment market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of End Stage Renal Disease Treatment industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of End Stage Renal Disease Treatment Include:
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
Nikkiso
WEGO
Newsol
Mayo Clinic
Guangdong Biolight
Sanxin Medtec
Medtronic
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
End Stage Renal Disease Treatment Product Segment Include:
Hemodialysis
Peritoneal Dialysis
Kidney Transplantation
End Stage Renal Disease Treatment Product Application Include:
Hospitals
Kidney Dialysis Centers
At Homes
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global End Stage Renal Disease Treatment Industry PESTEL Analysis
Chapter 3: Global End Stage Renal Disease Treatment Industry Porter’s Five Forces Analysis
Chapter 4: Global End Stage Renal Disease Treatment Major Regional Market Size and Forecast Analysis
Chapter 5: Global End Stage Renal Disease Treatment Market Size and Forecast by Type and Application Analysis
Chapter 6: North America End Stage Renal Disease Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe End Stage Renal Disease Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China End Stage Renal Disease Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) End Stage Renal Disease Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America End Stage Renal Disease Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa End Stage Renal Disease Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global End Stage Renal Disease Treatment Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 End Stage Renal Disease Treatment Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 End Stage Renal Disease Treatment Product by Type
- 1.2.1 Global End Stage Renal Disease Treatment Market Size by Type, 2023 VS 2024 VS 2030
- 1.2.2 Hemodialysis
- 1.2.3 Peritoneal Dialysis
- 1.2.4 Kidney Transplantation
- 1.3 End Stage Renal Disease Treatment Product by Application
- 1.3.1 Global End Stage Renal Disease Treatment Market Size by Application, 2023 VS 2024 VS 2030
- 1.3.2 Hospitals
- 1.3.3 Kidney Dialysis Centers
- 1.3.4 At Homes
- 1.3.5 Others
- 1.4 Global End Stage Renal Disease Treatment Market Revenue Analysis (2019-2030)
- 1.5 End Stage Renal Disease Treatment Market Development Status and Trends
- 1.5.1 End Stage Renal Disease Treatment Industry Development Status Analysis
- 1.5.2 End Stage Renal Disease Treatment Industry Development Trends Analysis
- 2 End Stage Renal Disease Treatment Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 End Stage Renal Disease Treatment Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global End Stage Renal Disease Treatment Market Analysis by Regions
- 4.1 End Stage Renal Disease Treatment Overall Market: 2023 VS 2024 VS 2030
- 4.2 Global End Stage Renal Disease Treatment Revenue and Forecast Analysis (2019-2030)
- 4.2.1 Global End Stage Renal Disease Treatment Revenue and Market Share by Region (2019-2024)
- 4.2.2 Global End Stage Renal Disease Treatment Revenue Forecast by Region (2025-2030)
- 5 Global End Stage Renal Disease Treatment Market Size by Type and Application
- 5.1 Global End Stage Renal Disease Treatment Market Size by Type
- 5.2 Global End Stage Renal Disease Treatment Market Size by Application
- 6 North America
- 6.1 North America End Stage Renal Disease Treatment Market Size and Growth Rate Analysis (2019-2030)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America End Stage Renal Disease Treatment Market Size by Type
- 6.4 North America End Stage Renal Disease Treatment Market Size by Application
- 6.5 North America End Stage Renal Disease Treatment Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe End Stage Renal Disease Treatment Market Size and Growth Rate Analysis (2019-2030)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe End Stage Renal Disease Treatment Market Size by Type
- 7.4 Europe End Stage Renal Disease Treatment Market Size by Application
- 7.5 Europe End Stage Renal Disease Treatment Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China End Stage Renal Disease Treatment Market Size and Growth Rate Analysis (2019-2030)
- 8.2 China Key Manufacturers Analysis
- 8.3 China End Stage Renal Disease Treatment Market Size by Type
- 8.4 China End Stage Renal Disease Treatment Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) End Stage Renal Disease Treatment Market Size and Growth Rate Analysis (2019-2030)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) End Stage Renal Disease Treatment Market Size by Type
- 9.4 APAC (excl. China) End Stage Renal Disease Treatment Market Size by Application
- 9.5 APAC (excl. China) End Stage Renal Disease Treatment Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Indonesia
- 9.5.6 Vietnam
- 9.5.7 Malaysia
- 9.5.8 Thailand
- 10 Latin America
- 10.1 Latin America End Stage Renal Disease Treatment Market Size and Growth Rate Analysis (2019-2030)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America End Stage Renal Disease Treatment Market Size by Type
- 10.4 Latin America End Stage Renal Disease Treatment Market Size by Application
- 10.5 Latin America End Stage Renal Disease Treatment Market Size by Country
- 10.5.1 Mecixo
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa End Stage Renal Disease Treatment Market Size and Growth Rate Analysis (2019-2030)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa End Stage Renal Disease Treatment Market Size by Type
- 11.4 Middle East & Africa End Stage Renal Disease Treatment Market Size by Application
- 11.5 Middle East & Africa End Stage Renal Disease Treatment Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Market Competition by Manufacturers
- 12.1 Global End Stage Renal Disease Treatment Market Revenue by Key Manufacturers (2020-2024)
- 12.2 End Stage Renal Disease Treatment Competitive Landscape Analysis and Market Dynamic
- 12.2.1 End Stage Renal Disease Treatment Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Fresenius
- 13.1.1 Fresenius Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Fresenius End Stage Renal Disease Treatment Product Portfolio
- 13.1.3 Fresenius End Stage Renal Disease Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.2 DaVita
- 13.2.1 DaVita Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 DaVita End Stage Renal Disease Treatment Product Portfolio
- 13.2.3 DaVita End Stage Renal Disease Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.3 Baxter
- 13.3.1 Baxter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Baxter End Stage Renal Disease Treatment Product Portfolio
- 13.3.3 Baxter End Stage Renal Disease Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.4 Nipro
- 13.4.1 Nipro Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Nipro End Stage Renal Disease Treatment Product Portfolio
- 13.4.3 Nipro End Stage Renal Disease Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.5 B. Braun
- 13.5.1 B. Braun Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 B. Braun End Stage Renal Disease Treatment Product Portfolio
- 13.5.3 B. Braun End Stage Renal Disease Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.6 Asahi Kasei
- 13.6.1 Asahi Kasei Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Asahi Kasei End Stage Renal Disease Treatment Product Portfolio
- 13.6.3 Asahi Kasei End Stage Renal Disease Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.7 Nikkiso
- 13.7.1 Nikkiso Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Nikkiso End Stage Renal Disease Treatment Product Portfolio
- 13.7.3 Nikkiso End Stage Renal Disease Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.8 WEGO
- 13.8.1 WEGO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 WEGO End Stage Renal Disease Treatment Product Portfolio
- 13.8.3 WEGO End Stage Renal Disease Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.9 Newsol
- 13.9.1 Newsol Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Newsol End Stage Renal Disease Treatment Product Portfolio
- 13.9.3 Newsol End Stage Renal Disease Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.10 Mayo Clinic
- 13.10.1 Mayo Clinic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Mayo Clinic End Stage Renal Disease Treatment Product Portfolio
- 13.10.3 Mayo Clinic End Stage Renal Disease Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.11 Guangdong Biolight
- 13.11.1 Guangdong Biolight Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Guangdong Biolight End Stage Renal Disease Treatment Product Portfolio
- 13.11.3 Guangdong Biolight End Stage Renal Disease Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.12 Sanxin Medtec
- 13.12.1 Sanxin Medtec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Sanxin Medtec End Stage Renal Disease Treatment Product Portfolio
- 13.12.3 Sanxin Medtec End Stage Renal Disease Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.13 Medtronic
- 13.13.1 Medtronic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Medtronic End Stage Renal Disease Treatment Product Portfolio
- 13.13.3 Medtronic End Stage Renal Disease Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.14 Jafron Biomedical
- 13.14.1 Jafron Biomedical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Jafron Biomedical End Stage Renal Disease Treatment Product Portfolio
- 13.14.3 Jafron Biomedical End Stage Renal Disease Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.15 SWS Hemodialysis Care
- 13.15.1 SWS Hemodialysis Care Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 SWS Hemodialysis Care End Stage Renal Disease Treatment Product Portfolio
- 13.15.3 SWS Hemodialysis Care End Stage Renal Disease Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.16 Tianyi Medical
- 13.16.1 Tianyi Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 Tianyi Medical End Stage Renal Disease Treatment Product Portfolio
- 13.16.3 Tianyi Medical End Stage Renal Disease Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 14 Industry Chain Analysis
- 14.1 End Stage Renal Disease Treatment Industry Chain Analysis
- 14.2 End Stage Renal Disease Treatment Industry Raw Material and Suppliers Analysis
- 14.2.1 Upstream Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 End Stage Renal Disease Treatment Typical Downstream Customers
- 14.4 End Stage Renal Disease Treatment Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
